The type of collection tube (EDTA or citrate) for blood samples is important. It is well known that MPV increases over time in EDTA-anticoagulated samples. The MPV increases up to 30% within 5 minutes of exposure with EDTA and increases further by 10% to 15% over 2 hours. 6 Choi et al 4 measured absolute neutrophil and lymphocyte counts and MPV within 2 hours after sample collections. Another limitation of using EDTA collection tubes is EDTA-dependent pseudothrombocytopenia; this may occur in a very low percentage of the general population. 7 The NLR has recently been accepted as a simple, costeffective, routine, inflammatory marker in many diseases. [1] [2] [3] For instance, the NLR is raised in patients with MS. Also, there was a significant correlation between the severity of MS and inflammation on the basis of NLR. 1 Other interesting study Yalcin et al 2 investigated the relation between NLR and left atrial thrombus. They concluded that it was an independent predictor for the presence of left atrium thrombus in patients with nonvalvular atrial fibrillation. 2 The NLR also correlates with cardiovascular events and is a simple and cheap test when compared with the other inflammatory markers such as C-reactive protein. 8 Furthermore, the NLR has predictive and prognostic values in many diseases. For instance, Behçet disease (BD) is associated with endothelial dysfunction and chronic inflammation. Ozturk et al 9 reported NLR might be a useful index of BD disease activity. 9 Authors should also keep in mind conditions like abnormal thyroid function tests, renal or hepatic dysfunction, malignancy, and local or systemic infection. 8 In this context, inflammatory diseases should be excluded. For example, BD may affect NLR levels. 9 Similar to MPV, NLR can be modified by some medications; antihypertensive drugs were shown to decrease the NLR. 10 The NLR is also influenced by dehydration, overhydration, diluted blood specimens, and in vitro blood specimen handling. 8 In conclusion, based on the work of Choi et al, 4 future work should evaluate the use of both MPV and NLR in clinical practice. Together, the NLR þ MPV may well turn out to be more useful predictors of vascular risk than either marker separately. However, laboratory-based artifacts, patient characteristics (including inflammatory status), and drug therapy should be considered as potential confounders. These requirements will impose substantial restrictions on such studies.
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